Physician profile
Kenneth Jackson Delay
NPI 1699092056
$8,914.10
in general payments reported to CMS, 2019-2025
33 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,419 · 2020: $1,648 · 2021: $682 · 2022: $378 · 2023: $412 · 2024: $228 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,961.92 | 2019-2024 | Titan, Speedicath |
| Astellas Pharma US INC | $819.94 | 2019-2021 | |
| Boston Scientific Corporation | $722.98 | 2019-2025 | Ams 700, Spaceoar Vue System - 10ml, General - Kidney Stone Disease |
| Allergan, INC. | $322.42 | 2019-2021 | |
| Pfizer INC. | $238.08 | 2019-2020 | |
| Amgen INC. | $225.73 | 2019-2021 | |
| Janssen Biotech, INC. | $162.46 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $160.93 | 2019-2021 | |
| Abbvie INC. | $149.94 | 2019-2021 | |
| Teleflex LLC | $148.84 | 2022-2023 | Urolift |
| Dendreon Pharmaceuticals LLC | $120.86 | 2019-2020 | |
| Calyxo, INC. | $113.80 | 2024 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $104.46 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.36 | 2019-2021 | |
| Olympus America INC. | $67.22 | 2020-2023 | Itind System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $66.75 | 2019-2025 | Zenith Spiral-Z, Cook |
| Innovation Technologies INC | $47.41 | 2024 | Irrisept |
| Laborie Medical Technologies Corp. | $42.80 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $40.11 | 2019 | |
| Axonics, INC. | $39.49 | 2020 | |
| Antares Pharma, INC. | $37.48 | 2019-2021 | |
| Myovant Sciences INC. | $34.27 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.88 | 2020-2021 | |
| Ambu INC. | $28.47 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $26.19 | 2024 | Lynparza |
| Rochester Medical Corporation | $22.93 | 2021 | |
| Blue Earth Diagnostics | $21.07 | 2021 | |
| Dentsply Ih INC. | $19.93 | 2021 | |
| Travere Therapeutics, INC. | $19.30 | 2021 | |
| Medtronic, INC. | $13.72 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $12.36 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Delay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.